Board Meetings for LALPATHLAB
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 08 Feb 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 06 Nov 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2018 and dividend | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 10 Aug 2018 | Financial Results | To consider and approve the Unaudited financial results for the period ended Jun 30, 2018. | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 14 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 08 Feb 2018 | Results | To inter-alia consider and approve the un-audited Financial Results of the Company for the Quarter ended December 31, 2017.�� | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 09 Nov 2017 | Results/Dividend | To inter-alia consider and approve the un-audited financial results of the Company for the Quarter & Half Year ended September 30, 2017 and to consider the proposal of payment of interim dividend, if any, for the Financial Year 2017-18. | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 07 Aug 2017 | Results | To inter-alia consider and approve the unaudited Financial Results of the Company for the Quarter ended June 30, 2017. | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 12 May 2017 | Results/Dividend | To inter-alia consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2017 and to consider recommending Final Dividend, if any, on Equity Shares of the Company for the Financial Year ended March 31, 2017. Further the Trading Window, as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company s code for Prevention of Insider Trading, will be closed from April 01, 2017 till May 14, 2017 for the purpose of announcement / declaration of such results by the Company. | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 02 Feb 2017 | Results/Dividend | To inter-alia consider and approve the un-audited financial results of the Company for the Quarter ended December 31, 2016 and to consider the proposal of payment on interim dividend, if any, for the financial Year 2016-17. Further, the Trading Window, as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's code for Prevention of Insider Trading, will be closed from January 01, 2017 till February 04, 2017 for the purpose of announcement / declaration of such results by the Company. | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 03 Nov 2016 | Results | Inter-alia consider and approve the unaudited financial results of the Company for the quarter & half year ended September 30, 2016. | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 29 Jul 2016 | Results | To inter-alia consider and approve the unaudited financial results of the Company for the Quarter ended June 30, 2016. | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 27 May 2016 | Results/Dividend | To inter-alia consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2016 and to consider recommending dividend, if any, on Equity Shares of the Company for the year ended March 31, 2016. | |
| LALPATHLAB | Dr. Lal Path Labs Ltd. | 12 Feb 2016 | Results | to inter-alia consider and approve the un-audited financial results of the Company for the quarter and nine-months ended December 31, 2015. |
Showing page 4 of 4 (58 total items)